Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0156 | 0.5158 | 0.5 |
Trichomonas vaginalis | glycoside hydrolase, putative | 0.0156 | 0.5158 | 0.5 |
Entamoeba histolytica | beta-galactosidase, putative | 0.0081 | 0.0468 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.1572 | 0.1572 |
Loa Loa (eye worm) | beta-glucuronidase | 0.0075 | 0.0077 | 0.0077 |
Loa Loa (eye worm) | glycosyl hydrolase family 2 | 0.0081 | 0.0468 | 0.0468 |
Schistosoma mansoni | hypothetical protein | 0.0081 | 0.0468 | 0.2978 |
Brugia malayi | Beta-glucuronidase precursor | 0.0075 | 0.0077 | 0.0223 |
Brugia malayi | Glycosyl hydrolases family 2, sugar binding domain containing protein | 0.0081 | 0.0468 | 0.135 |
Trichomonas vaginalis | beta-galactosidase, putative | 0.0156 | 0.5158 | 0.5 |
Echinococcus multilocularis | beta galactosidase | 0.0099 | 0.1572 | 1 |
Schistosoma mansoni | beta-galactosidase | 0.0099 | 0.1572 | 1 |
Echinococcus granulosus | beta galactosidase | 0.0099 | 0.1572 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.1572 | 0.1572 |
Brugia malayi | manba-prov protein | 0.0129 | 0.3467 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.734 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.705 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.467 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.426 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.419 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.416 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.381 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.368 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.366 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.327 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.307 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | > 5 uM | Cytotoxicity against human DU145 cells after 48 hrs by MTT assay | ChEMBL. | 22708987 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 22708987 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.